Patrick Wen has been appointed as the new Editor-in-Chief of the Society’s flagship journal, Neuro-Oncology. Dr. Wen is Professor of Neurology at Harvard Medical School and Director of the Center for Neuro-Oncology at Dana-Farber/Brigham and Women’s Cancer Center in Boston, Massachusetts. He was formerly Vice President of SNO and is currently Chair of the Neuro-Oncology Section of the American Academy of Neurology. His research focuses on novel therapeutics for brain tumors and optimizing response assessment and trial designs.
Dr. Wen succeeds Dr. W. K. Alfred Yung who was appointed Editor-in-Chief of Neuro-Oncology in 2007. The journal’s Founding Editor was Dr. Darell Bigner, who worked to establish Neuro-Oncology as the seminal publication in the field. During Dr. Yung’s tenure, the journal increased in frequency from four issues to twelve issues per year; in addition, Dr. Yung guided the journal’s Impact Factor to an impressive 6.180, which puts Neuro-Oncology among the world’s top oncology and neurology titles.
Dr. Wen looks forward to working with the European Association for Neuro-Oncology (EANO), and the Japanese Society For Neuro-Oncology (JSNO) to build on Dr. Yung's legacy in making Neuro-Oncology the foremost journal in the field and advancing our mission of developing better treatments and improving the quality of life of brain tumor patients and patients with neurologic complications of cancer.
Neuro-Oncology is the official journal of the Society for Neuro-Oncology, and is published by Oxford University Press.